CREALIA backs AEGIS BIO’s next stage of development
AEGIS BIO is delighted to receive the support of CREALIA, providing new momentum to the company as we advance our preclinical development and prepare for the next stages of growth.
This support is also a strong recognition of AEGIS BIO’s commitment to building its future within the Montpellier and Languedoc life-sciences ecosystem. By developing our activities locally and engaging with regional scientific, entrepreneurial, and investment networks, we aim to contribute to a rapidly growing environment for biotechnology and healthcare innovation.
This milestone will help AEGIS BIO continue transforming its science into therapeutic solutions designed to reduce the severe toxicities associated with life-saving treatments and improve patients’ long-term quality of life.